In another study, 111In-labeled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer were reported to achieve combinational and targeted therapeutic effects in cancer cells that overexpress EGFR (Human Epidermal Growth Factor Receptor) (Ng et al., 2014; Gill et al., 2018). The gene discussed is EGFR; the disease is cancer.